These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 11496922)

  • 1. Glial tumor invasion: a role for the upregulation and cleavage of BEHAB/brevican.
    Nutt CL; Matthews RT; Hockfield S
    Neuroscientist; 2001 Apr; 7(2):113-22. PubMed ID: 11496922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for proteolytic cleavage of brevican by the ADAMTSs in the dentate gyrus after excitotoxic lesion of the mouse entorhinal cortex.
    Mayer J; Hamel MG; Gottschall PE
    BMC Neurosci; 2005 Aug; 6():52. PubMed ID: 16122387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioma actively orchestrate a self-advantageous extracellular matrix to promote recurrence and progression.
    Wei R; Zhou J; Bui B; Liu X
    BMC Cancer; 2024 Aug; 24(1):974. PubMed ID: 39118096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BEHAB (brain enriched hyaluronan binding) is expressed in surgical samples of glioma and in intracranial grafts of invasive glioma cell lines.
    Jaworski DM; Kelly GM; Piepmeier JM; Hockfield S
    Cancer Res; 1996 May; 56(10):2293-8. PubMed ID: 8625302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BEHAB/brevican: a brain-specific lectican implicated in gliomas and glial cell motility.
    Gary SC; Kelly GM; Hockfield S
    Curr Opin Neurobiol; 1998 Oct; 8(5):576-81. PubMed ID: 9811619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of BEHAB/Brevican in the Tumor Microenvironment: Mediating Glioma Cell Invasion and Motility.
    Giamanco KA; Matthews RT
    Adv Exp Med Biol; 2020; 1272():117-132. PubMed ID: 32845505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brevican: a key proteoglycan in the perisynaptic extracellular matrix of the brain.
    Frischknecht R; Seidenbecher CI
    Int J Biochem Cell Biol; 2012 Jul; 44(7):1051-4. PubMed ID: 22537913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced expression of the hyaluronan and proteoglycan link proteins in malignant gliomas.
    Sim H; Hu B; Viapiano MS
    J Biol Chem; 2009 Sep; 284(39):26547-56. PubMed ID: 19633295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The proteoglycan brevican binds to fibronectin after proteolytic cleavage and promotes glioma cell motility.
    Hu B; Kong LL; Matthews RT; Viapiano MS
    J Biol Chem; 2008 Sep; 283(36):24848-59. PubMed ID: 18611854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion.
    Viapiano MS; Hockfield S; Matthews RT
    J Neurooncol; 2008 Jul; 88(3):261-72. PubMed ID: 18398576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human glioblastomas overexpress ADAMTS-5 that degrades brevican.
    Nakada M; Miyamori H; Kita D; Takahashi T; Yamashita J; Sato H; Miura R; Yamaguchi Y; Okada Y
    Acta Neuropathol; 2005 Sep; 110(3):239-46. PubMed ID: 16133547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lectin DrfL inhibits cell migration, adhesion and triggers autophagy-dependent cell death in glioma cells.
    Wolin IAV; Nascimento APM; Seeger R; Poluceno GG; Zanotto-Filho A; Nedel CB; Tasca CI; Correia SEG; Oliveira MV; Pinto-Junior VR; Osterne VJS; Nascimento KS; Cavada BS; Leal RB
    Glycoconj J; 2023 Feb; 40(1):47-67. PubMed ID: 36522582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation-Induced Alterations in the Recurrent Glioblastoma Microenvironment: Therapeutic Implications.
    Gupta K; Burns TC
    Front Oncol; 2018; 8():503. PubMed ID: 30467536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value and their clinical implication of 89-gene signature in glioma.
    Shahid M; Cho KM; Nguyen MN; Choi TG; Jo YH; Aryal SN; Yoo JY; Yun HR; Lee JW; Eun YG; Lee JS; Kang I; Ha J; Yoon HJ; Kim SY; Kim SS
    Oncotarget; 2016 Aug; 7(32):51237-51250. PubMed ID: 27323413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Concomitant Radiochemotherapy on Invasion Potential of Glioblastoma.
    Hutóczki G; Bognár L; Tóth J; Scholtz B; Zahuczky G; Hanzély Z; Csősz É; Reményi-Puskár J; Kalló G; Hortobágyi T; Klekner A
    Pathol Oncol Res; 2016 Jan; 22(1):155-60. PubMed ID: 26450124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sugar glues for broken neurons.
    Swarup VP; Mencio CP; Hlady V; Kuberan B
    Biomol Concepts; 2013 Jun; 4(3):233-57. PubMed ID: 25285176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of brevican in glioma: promoting tumor cell motility in vitro and in vivo.
    Lu R; Wu C; Guo L; Liu Y; Mo W; Wang H; Ding J; Wong ET; Yu M
    BMC Cancer; 2012 Dec; 12():607. PubMed ID: 23253190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid regeneration: characterization of clear cells after partial thyroidectomy.
    Ozaki T; Matsubara T; Seo D; Okamoto M; Nagashima K; Sasaki Y; Hayase S; Murata T; Liao XH; Hanson J; Rodriguez-Canales J; Thorgeirsson SS; Kakudo K; Refetoff S; Kimura S
    Endocrinology; 2012 May; 153(5):2514-25. PubMed ID: 22454152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brevican, neurocan, tenascin-C and versican are mainly responsible for the invasiveness of low-grade astrocytoma.
    Varga I; Hutóczki G; Szemcsák CD; Zahuczky G; Tóth J; Adamecz Z; Kenyeres A; Bognár L; Hanzély Z; Klekner A
    Pathol Oncol Res; 2012 Apr; 18(2):413-20. PubMed ID: 21997179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular matrix abnormalities in schizophrenia.
    Berretta S
    Neuropharmacology; 2012 Mar; 62(3):1584-97. PubMed ID: 21856318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.